Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Swedish firm Oasmia Pharmaceutical has completed the spin-off of its veterinary oncology business into a US subsidiary called AdvaVet.
The first company focused on a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition has been created.
Canadian veterinary diagnostics company Biovet has begun a Can$2.25 million ($1.75 million) expansion of its headquarters, with construction expected to be completed in July.
US parasite control company TyraTech has made progress in ramping up its product sales after it decided to focus solely on animal health.
Zomedica Pharmaceuticals has recorded a higher net loss in the first quarter of 2018, as it builds out the company and continues investing in R&D.
Denmark's leading aquaculture feed company BioMar has invested in additional capacity at its main non-salmon production facility.
Australian firm Anatara Lifesciences has announced its executive chairman Mel Bridges will be retiring.
UK animal health firm Animalcare has posted strong revenue growth for 2017, following its merger with Belgian company Ecuphar.
Boehringer Ingelheim has underscored its animal health business strategy for China by expanding its research center in the north east of the country.
US animal nutrition and feed additive specialist Archer Daniels Midland (ADM) has opened a new pre-mix factory.
The shares of Australian firm Anatara Lifesciences have been halted from trading pending an announcement by the company.
Boehringer Ingelheim now has the largest animal health business among the leading human pharma companies.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.